These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7097945)

  • 1. Risk factors for development of toxic shock syndrome. Association with a tampon brand.
    Schlech WF; Shands KN; Reingold AL; Dan BB; Schmid GP; Hargrett NT; Hightower A; Herwaldt LA; Neill MA; Band JD; Bennett JV
    JAMA; 1982 Aug; 248(7):835-9. PubMed ID: 7097945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.
    Shands KN; Schmid GP; Dan BB; Blum D; Guidotti RJ; Hargrett NT; Anderson RL; Hill DL; Broome CV; Band JD; Fraser DW
    N Engl J Med; 1980 Dec; 303(25):1436-42. PubMed ID: 7432402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of tampon characteristics to menstrual toxic shock syndrome.
    Berkley SF; Hightower AW; Broome CV; Reingold AL
    JAMA; 1987 Aug; 258(7):917-20. PubMed ID: 3613021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tri-state toxic-state syndrome study. I. Epidemiologic findings.
    Osterholm MT; Davis JP; Gibson RW; Mandel JS; Wintermeyer LA; Helms CM; Forfang JC; Rondeau J; Vergeront JM
    J Infect Dis; 1982 Apr; 145(4):431-40. PubMed ID: 7069223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal tampon model for toxic shock syndrome.
    Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
    Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic shock syndrome and tampons.
    Schuchat A; Broome CV
    Epidemiol Rev; 1991; 13():99-112. PubMed ID: 1662639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic shock syndrome: an update.
    Reingold AL
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1236-9. PubMed ID: 1951580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic shock and tampons. Evaluation of the epidemiologic evidence.
    Harvey M; Horwitz RI; Feinstein AR
    JAMA; 1982 Aug; 248(7):840-6. PubMed ID: 7047782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic shock syndrome in Canada.
    Clayton AJ; Peacocke JE; Ewan PE
    Can Med Assoc J; 1982 Apr; 126(7):776-9. PubMed ID: 7042059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for staphylococcal toxic-shock syndrome.
    Kehrberg MW; Latham RH; Haslam BT; Hightower A; Tanner M; Jacobson JA; Barbour AG; Noble V; Smith CB
    Am J Epidemiol; 1981 Dec; 114(6):873-9. PubMed ID: 7315834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic shock syndrome and other tampon related risks.
    Cibulka NJ
    JOGN Nurs; 1983; 12(2):94-9. PubMed ID: 6551545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study.
    Reingold AL; Broome CV; Gaventa S; Hightower AW
    Rev Infect Dis; 1989; 11 Suppl 1():S35-41; discussion S41-2. PubMed ID: 2928651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent menstrual toxic shock syndrome despite discontinuation of tampon use: is menstrual toxic shock syndrome really caused by tampons?
    Dixit S; Fischer G; Wittekind C
    Australas J Dermatol; 2013 Nov; 54(4):283-6. PubMed ID: 22897229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic shock syndrome.
    Tofte RW; Williams DN
    Postgrad Med; 1983 Jan; 73(1):275-80, 285-8. PubMed ID: 6336841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.
    Davis JP; Chesney PJ; Wand PJ; LaVenture M
    N Engl J Med; 1980 Dec; 303(25):1429-35. PubMed ID: 7432401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic shock syndrome: relation to catamenial products, personal health and hygiene, and sexual practices.
    Osterholm MT; Davis JP; Gibson RW; Forfang JC; Stolz SJ; Vergeront JM
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):954-8. PubMed ID: 7091973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical safety assessment of an ultra absorbency menstrual tampon.
    Hochwalt AE; Jones MB; Meyer SJ
    J Womens Health (Larchmt); 2010 Feb; 19(2):273-8. PubMed ID: 20109120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic-shock syndrome, United States, 1970-1982.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Apr; 31(16):201-4. PubMed ID: 6804780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device-Associated Menstrual Toxic Shock Syndrome.
    Schlievert PM; Davis CC
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32461307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic shock syndrome in Oregon: epidemiologic findings.
    Helgerson SD; Foster LR
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):909-11. PubMed ID: 7091966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.